Koen van Besien Selected Research

Koen van Besien Research Topics

Disease

17	Neoplasms (Cancer) 02/2024 - 10/2003
14	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 03/2003
14	Lymphoma (Lymphomas) 12/2020 - 10/2003
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2020 - 10/2003
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 08/2005
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019 - 11/2003
7	Leukemia 10/2020 - 03/2003
7	Bronchiolitis Obliterans Syndrome 01/2017 - 08/2006
6	Infections 09/2023 - 09/2007
6	Neutropenia 10/2021 - 05/2013
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 08/2005
4	Sickle Cell Anemia (Hemoglobin S Disease) 01/2023 - 03/2010
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2020 - 11/2009
4	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 09/2007
3	Multiple Myeloma 12/2019 - 06/2002
3	Primary Myelofibrosis (Myelosclerosis) 05/2016 - 03/2002
3	Hodgkin Disease (Hodgkin's Disease) 03/2014 - 07/2005
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2011 - 03/2008
2	Sepsis (Septicemia) 10/2021 - 12/2014
2	Human Influenza (Influenza) 08/2020 - 12/2019
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 11/2010
2	Hypoalbuminemia 01/2019 - 10/2015
2	Bacteremia 11/2018 - 12/2014
2	Thrombocytopenia (Thrombopenia) 09/2017 - 12/2012
2	Viremia 03/2016 - 09/2009
2	Fatigue 05/2013 - 05/2006
2	Opportunistic Infections (Opportunistic Infection) 12/2011 - 08/2011
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2024
1	Immune Reconstitution Inflammatory Syndrome 09/2023
1	Inflammation (Inflammations) 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	COVID-19 01/2022
1	Virus Diseases (Viral Diseases) 12/2021
1	Epstein-Barr Virus Infections 12/2021
1	Fever (Fevers) 01/2021
1	Cytomegalovirus Infections (Inclusion Disease) 12/2020
1	Cytokine Release Syndrome 11/2020
1	Residual Neoplasm 01/2019
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2019
1	Pathologic Complete Response 01/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Febrile Neutropenia 01/2018
1	Disease Progression 09/2017
1	Splenomegaly 05/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2016
1	Acute Kidney Injury (Acute Renal Failure) 12/2014

Drug/Important Bio-Agent (IBA)

11	Alemtuzumab (Campath)FDA Link 01/2022 - 08/2005
8	Melphalan (Alkeran)FDA LinkGeneric 12/2019 - 06/2002
6	fludarabineIBA 01/2018 - 08/2005
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 04/2015
5	Busulfan (Busulfex)FDA Link 03/2014 - 03/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 03/2003
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021 - 11/2016
2	Levofloxacin (Levaquin)FDA Link 10/2021 - 11/2018
2	Vancomycin FDA LinkGeneric 01/2021 - 12/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 12/2011
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018 - 05/2009
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2018 - 03/2003
2	plerixafor FDA Link 01/2018 - 01/2018
2	CreatinineIBA 12/2014 - 09/2009
2	Clofarabine (Clolar)FDA Link 12/2014 - 06/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2012 - 10/2011
2	Imatinib Mesylate (Gleevec)FDA Link 10/2011 - 03/2008
2	Rituximab (Mabthera)FDA Link 11/2009 - 02/2007
1	RibonucleoproteinsIBA 01/2024
1	Messenger RNA (mRNA)IBA 10/2023
1	cc-486IBA 01/2023
1	thymoglobulin FDA Link 12/2021
1	tisagenlecleucelIBA 11/2020
1	tocilizumab (atlizumab)FDA Link 11/2020
1	Chimeric Antigen ReceptorsIBA 11/2020
1	Neuraminidase (Sialidase)IBA 08/2020
1	Oseltamivir (Tamiflu)FDA Link 08/2020
1	baloxavirIBA 08/2020
1	Bendamustine Hydrochloride FDA Link 12/2019
1	Antiviral Agents (Antivirals)IBA 12/2019
1	tofacitinibIBA 01/2019
1	ruxolitinibIBA 01/2019
1	Janus Kinase InhibitorsIBA 01/2019
1	Lenalidomide (CC 5013)FDA Link 09/2017
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	LactamsIBA 12/2014
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 03/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2013
1	CPX-351IBA 07/2013

Therapy/Procedure

19	Stem Cell Transplantation 01/2023 - 12/2004
17	Therapeutics 02/2024 - 03/2002
17	Transplantation 01/2018 - 03/2002
16	Hematopoietic Stem Cell Transplantation 09/2023 - 10/2003
10	Homologous Transplantation 05/2016 - 03/2003
8	Cell Transplantation 12/2021 - 05/2006
6	Drug Therapy (Chemotherapy) 10/2021 - 05/2006
6	Autologous Transplantation 01/2019 - 06/2002
2	Immunotherapy 12/2020 - 01/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2020 - 01/2019
2	Length of Stay 12/2011 - 11/2008
2	Photopheresis 12/2011 - 10/2008
1	Precision Medicine 01/2019
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2018
1	Hematopoietic Stem Cell Mobilization 11/2016